Strategic Blueprint LLC Sells 361 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Strategic Blueprint LLC trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 28.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 916 shares of the biotechnology company’s stock after selling 361 shares during the quarter. Strategic Blueprint LLC’s holdings in Axon Enterprise were worth $544,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Robeco Institutional Asset Management B.V. lifted its holdings in Axon Enterprise by 5.1% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 65,243 shares of the biotechnology company’s stock valued at $38,775,000 after buying an additional 3,141 shares in the last quarter. Asset Dedication LLC raised its stake in shares of Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $91,000. SteelPeak Wealth LLC grew its stake in Axon Enterprise by 125.6% in the fourth quarter. SteelPeak Wealth LLC now owns 1,453 shares of the biotechnology company’s stock worth $864,000 after purchasing an additional 809 shares in the last quarter. Finally, Mayflower Financial Advisors LLC purchased a new position in Axon Enterprise during the 4th quarter worth $256,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Trading Down 0.2 %

Axon Enterprise stock opened at $652.18 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market cap of $49.73 billion, a PE ratio of 168.52, a price-to-earnings-growth ratio of 6.41 and a beta of 1.04. The stock has a 50-day moving average of $619.63 and a two-hundred day moving average of $481.39. Axon Enterprise, Inc. has a one year low of $247.04 and a one year high of $698.67.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now owns 208,166 shares of the company’s stock, valued at $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 in the last three months. 6.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on AXON. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Finally, Needham & Company LLC upped their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $524.85.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.